Aster Guardians Global Nursing Award Unveils Top 10 Finalists for 2025 - Middle East Business News and Information
Dubai, United Arab Emirates: The Aster Guardians Global Nursing Award has today announced its Top 10 finalists for 2025, one of whom will go on to win the grand prize of USD 250,000. The finalists for the fourth edition of the awards were selected from a pool of 100,000+ registrations received from 199* countries worldwide. These finalists were selected following a rigorous evaluation process, led by esteemed expert jury and grand jury panels. The entire process was independently moderated by the appointed 'Process Advisors' Ernst & Young LLP.
The top 10 finalists for 2025 includes: Catherine Maree Holliday (Switzerland), Edith Namba (Papua New Guinea), Fitz Gerald Dalina Camacho (UAE), Dr. Jed Ray Gengoba Montayre (Hong Kong SAR), Dr. Jose Arnold Tariga (USA), Khadija Mohamed Juma (Kenya), Maheswari Jaganathan (Malaysia), Naomi Oyoe Ohene Oti (Ghana), Dr. Sukhpal Kaur (India), Vibhaben Gunvantbhai Salaliya (India). To know more about the top 10 finalists, please visit: asterguardians. com
Dr Azad Moopen, Founder Chairman, Aster DM Healthcare, said ' The Top 10 finalists have demonstrated extraordinary dedication, skill, and compassion in their work – selected from over 100,000 registrations that were received for the 4th edition of Aster Guardians Global Nursing Award. These nurses are not just healthcare providers, but true leaders, pushing boundaries and making a profound impact in their communities. Their exceptional contributions deserve to be recognized, and through this award, we celebrate their passion and commitment to improving lives across the globe.'
The final stage will involve public voting and interviews with distinguished members of the Grand Jury, with the winner set to be announced at a gala event in Dubai, UAE on May 26, 2025.
*As per data.worldbank.org/country
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CairoScene
14-05-2025
- CairoScene
Advanced Cancer Therapy to Be Produced in UAE at 90% Lower Cost
CAR-T cancer therapy—one of the world's most expensive treatments—will soon be produced locally in the UAE at a fraction of the price. Apr 20, 2025 In a major healthcare breakthrough, the UAE is set to manufacture CAR-T cell therapies locally, cutting treatment costs by up to 90% compared to international prices. The initiative, announced during Abu Dhabi Global Health Week, results from a partnership between Burjeel Holdings and US-based non-profit Caring Cross. CAR-T therapy is a next-generation immunotherapy that reprograms a patient's immune cells to target and destroy cancer cells, primarily used to treat aggressive blood cancers like leukemia and lymphoma. With current global treatment prices ranging from USD 350,000 to over USD 1 million, access has remained limited across the MENA region. This new initiative will establish a local manufacturing ecosystem, with Caring Cross supplying the technology, raw materials, and training needed to support point-of-care production. The first phase focuses on leukemia and lymphoma, with plans to expand into treatments for other diseases, including HIV. The partnership aims to position the UAE as a regional hub for advanced cell and gene therapies, enhancing access to life-saving treatments and supporting healthcare sustainability across underserved populations in MENA and beyond.
Mid East Info
13-05-2025
- Mid East Info
53-year-old British National with Complex Gastrointestinal Conditions Successfully Treated at Aster Cedars Hospital and Clinic, Jebel Ali
Aster Cedars Hospital and Clinic, Jebel Ali, a part of the leading integrated healthcare provider – Aster DM Healthcare, has once again demonstrated its expertise in advanced gastrointestinal care by successfully treating a complex case involving multiple severe gastrointestinal conditions. The patient, 53-year-old Michael Anthony John Caselberg, a British national, presented with a combination of symptoms, including altered bowel habits, chest discomfort, and severe acid reflux. Through expert diagnosis and state-of-the-art medical interventions, Aster Cedars Hospital's multidisciplinary team delivered exceptional results. Mr. Caselberg was diagnosed with several serious conditions: moderate inflammation of the food pipe caused by acid reflux (Grade B Reflux Esophagitis), a large hernia where part of the stomach pushes into the chest (large hiatus hernia), changes in the food pipe lining that can increase cancer risk (Barrett's esophagus), inflammation and damage in the stomach and small intestine (erosive gastroduodenitis), and growths in the colon (multiple colonic polyps). These conditions are rare and can lead to serious complications, especially the potential for cancer in the case of Barrett's esophagus. Large hiatus hernias are found in less than 5% of people with hernias, and Barrett's esophagus affects 1-2% of people with chronic GERD / long-term acid reflux.1 These statistics emphasize how rare and serious Mr. Caselberg's case is, highlighting the need for quick and accurate diagnosis and treatment. Over the past decade, more people in the UAE have been experiencing chronic acid reflux (GERD). In 2014, the Emirates Gastroenterology Society reported that over 30% of the UAE population (about 3 million people) suffered from acid reflux.3 GERD was found in 13.5% of the population, with a higher rate (19.2%) among adults over 30. Key risk factors for GERD include age, lack of sleep, arthritis, and depression. However, regular exercise was found to reduce the risk.[1] After thorough evaluation using advanced diagnostic tools such as Endoscopy, Colonoscopy, and imaging, the team identified and accurately staged the patient's conditions. To address the large hiatus hernia and associated reflux issues, Mr. Caselberg underwent Laparoscopic Fundoplication—a minimally invasive surgical procedure performed by Dr. Sandeep Patil, Specialist General Surgery, at Aster Cedars Hospital. This advanced surgery addressed the large hiatus hernia, strengthened the lower esophagus, and prevented further acid reflux, ensuring a faster recovery and reduced post-operative complications. Dr. Sandeep Ramesh Sharma, Specialist Gastroenterology, Aster Cedars Hospital and Clinic, Jebel Ali, who led the initial diagnostic evaluation, explained, 'The successful treatment of Mr. Caselberg's multiple gastrointestinal conditions highlights the importance of a multidisciplinary approach. Our team worked together to ensure precise diagnosis and optimal surgical intervention. The laparoscopic fundoplication procedure has provided him with much-needed symptom relief and sets a high standard for gastrointestinal care in the region.' Mr. Caselberg, who was discharged in stable condition on November 2, 2024, after a smooth recovery, expressed his gratitude towards the medical team at Aster Cedars Hospital. 'I am incredibly thankful to Dr. Sandeep Ramesh Sharma, Dr. Sandeep Patil, and the entire medical staff at Aster Cedars Hospital for their outstanding care. They not only diagnosed my conditions accurately but also performed the surgery with such skill that I have already experienced a dramatic improvement in my health. I am now looking forward to my recovery with confidence,' Mr. Caselberg said. The patient's post-operative recovery has been smooth, with no complications, and he reported significant symptom relief during his follow-up visit on November 9, 2024. This case underscores Aster Cedars Hospital's ability to manage complex gastrointestinal conditions and perform challenging procedures with expertise. Dr. Sandeep Patil, Specialist General Surgery, Aster Cedars Hospital and Clinic, Jebel Ali remarked, 'Laparoscopic fundoplication is a highly effective and minimally invasive technique for addressing large hiatus hernias and severe acid reflux. The procedure's high success rate globally—ranging from 90-95%—is a testament to its effectiveness.2 I'm pleased with Mr. Caselberg's outcome, which reflects our hospital's commitment to providing the best care possible.' This successful intervention highlights Aster Cedars Hospital and Clinic's position as a leading healthcare provider in the region for complex gastrointestinal conditions. The hospital's proficiency in diagnostics, surgical interventions, and personalized post-operative care continues to set a benchmark for medical excellence in the UAE.
El Fagr
07-05-2025
- El Fagr
Valu Announces Partnership with Vezeeta and Geidea to Offer Affordable Payment Solutions for Vezeeta's Shamel Subscription and Soon Other Healthcare Services via Geidea's
Valu Announces Partnership with Vezeeta and Geidea to Offer Affordable Payment Solutions for Vezeeta's Shamel Subscription and Soon Other Healthcare Services via Geidea's Payment Gateway Cairo، May 7، 2025 Valu، MENA's leading universal financial technology powerhouse، announced today a collaboration with Vezeeta Lab، the Innovation Hub of MENA's leading health-tech platform Vezeeta، and Geidea، a renowned payment solutions provider. This partnership will help make healthcare services in Egypt more accessible، affordable، and seamless for millions of patients. Valu continues strengthening its presence in the healthcare sector by partnering with Vezeeta، building on previous milestones to integrate fintech solutions into health-tech. This collaboration provides flexible payment plans through Geidea's cashless payment options to ease financial barriers to essential care. Central to this effort is Vezeeta's flagship program، Shamel، a subscription-based program offering high-quality healthcare services at significantly reduced prices. Valu will offer flexible payment plans for Shamel، different medical services، and pharmaceutical products، ensuring broader access to affordable healthcare. Shamel provides discounts of up to 80% on a wide range of healthcare services. These include surgeries، laboratory tests and scans، doctor consultations، dentistry، and in-clinic services through a network of over 8،000 healthcare providers across Egypt. As Vezeeta rolls out online payment options across its network، Valu's flexible payment plans will also become available for various services، including doctor consultations، lab tests and scans، surgeries، and elective care. Motaz Lotfy، Senior Director of Business Development and Partnerships at Valu، commented on the partnership، 'With 90% of Egypt's population lacking private health insurance coverage and incurring out-of-pocket healthcare expenses reaching USD 180 million annually، there is an urgent need for access to affordable healthcare solutions in the community. We are excited to leverage our fintech expertise alongside Vezeeta and Geidea to address this area. Together، we are creating new opportunities for Egyptians، enabling them to prioritize their health without facing financial strain. By integrating Valu's innovative solutions into the health-tech sector، we provide effective payment solutions and empower lives through a meaningful impact.' Ola Aly Eldin، Chief Operating Officer at Vezeeta، added، 'At Vezeeta، we believe that no one should have to choose between their health and financial burdens. The launch of Shamel and our collaboration with Valu and Geidea demonstrates our strong commitment to providing high-quality healthcare that is accessible and affordable. With the rising costs of healthcare services، many people face limited options for getting the care they need، Shamel steps in to drive affordability and make quality healthcare within reach for all segments of the Egyptian society in a full digital experience through Vezeeta App. Choucri Asmar، Chief Corporate Development Officer at Vezeeta & Head of Vezeeta Lab، said، 'At Vezeeta Lab، we focus on partnerships and M&As that bring innovation supporting Vezeeta customers. In our commitment to merge fintech solutions with healthtech، this tripartite partnership between ValU، Geidea، and Vezeeta Lab will offer payment plans and cashless payment options with flexible financing، empowering millions of Egyptians to access the best healthcare without the financial burden.' Ahmed Nader، CEO of Geidea Egypt، commented، 'At Geidea Egypt، we provide innovative digital payment solutions that meet the evolving needs of the Egyptian market and promote financial inclusion. Our partnership with Valu and Vezeeta represents a significant step toward improving the digital payment experience، especially in the healthcare sector، by offering users seamless and secure payment options. This collaboration highlights our commitment to delivering advanced technological solutions that facilitate business growth and simplify financial transactions for businesses and consumers.'
